LC-MS Ampholyte Lot Characterization for Direct CIEF Suitability

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Existing methods for characterizing ampholyte compositions for use in techniques like capillary isoelectric focusing (CIEF) are indirect, costly, and time-consuming, relying on large protein quantities and generating electropherograms, which do not directly assess ampholyte suitability.

Innovation Solution

A method using liquid chromatography-mass spectrometry (LC-MS) to identify markers in ampholyte compositions by Accurate Mass/Retention Time (AMRT) or collision cross section (CCS) measurements, plotting covariance in an S-plot, and selecting markers for similarity or difference to determine ampholyte suitability.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If indirect methods (electropherogram comparison) are used to characterize ampholyte compositions, then ampholyte suitability can be assessed, but the analysis is costly, time-consuming, and requires large protein quantities

Engineering Contradiction:
Improveampholyte composition characterization accuracyVSAvoidanalysis time
Core Design Contradiction:
Measurement precisionVSLoss of time

Solution Approach 1:

The patent extracts the essential characteristics of ampholyte compositions by identifying specific mass spectrometry markers that directly indicate ampholyte quality and consistency. Instead of using indirect electropherogram comparisons, the method isolates and measures key marker ions (e.g., m/z 966.5, 1008.5, 1050.5) that represent critical ampholyte components, enabling direct assessment without requiring protein samples or time-consuming electrophoresis runs

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent replaces the mechanical/electrophoretic separation system (CIEF requiring proteins, ampholytes, and electrical fields) with a mass spectrometry-based analytical system. This substitution eliminates the need for biological materials and complex electrophoresis apparatus, reducing both time and cost while maintaining or improving measurement precision through direct molecular detection

Inventive Principle:
Principle #28Mechanics substitution (Replace mechanical system)

2Measurement precision

If indirect methods (electropherogram comparison) are used to characterize ampholyte compositions, then ampholyte suitability can be assessed, but large quantities of protein are required

Engineering Contradiction:
Improveampholyte composition characterization accuracyVSAvoidprotein quantity
Core Design Contradiction:
Measurement precisionVSQuantity of substance

Solution Approach 1:

The method extracts and measures only the essential ampholyte marker ions directly through mass spectrometry, eliminating the need to use protein substances as proxies. By focusing on specific ampholyte-derived ions (m/z 966.5, 1008.5, 1050.5, etc.), the technique obtains accurate composition data without consuming any protein material

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent introduces mass spectrometry as an intermediary analytical technique that directly probes ampholyte compositions without requiring protein mediators. The MS system detects ampholyte ions themselves, serving as a direct intermediary between the ampholyte sample and the assessment criterion, thereby eliminating the need for protein substances entirely

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If lot-to-lot variation in ampholyte compositions is not characterized, then production continues, but assay results become inconsistent and unreliable

Engineering Contradiction:
Improveproduction continuityVSAvoidassay result consistency
Core Design Contradiction:
ProductivityVSReliability

Solution Approach 1:

The patent implements preliminary characterization of ampholyte lots using mass spectrometry marker analysis before these lots are used in CIEF assays. By assessing key marker ion intensities (m/z 966.5, 1008.5, 1050.5) in advance, the method identifies suitable ampholyte lots proactively, ensuring assay reliability before production activities begin, while allowing rapid rejection of unsuitable lots to maintain productivity

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The method establishes a feedback mechanism where mass spectrometry analysis of ampholyte marker ions provides quantitative data on composition variation between lots. This feedback information (marker ion intensity ratios) is used to evaluate and select ampholyte lots, creating a closed-loop quality control system that maintains both production continuity and assay reliability through data-driven decisions

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach allows for rapid, direct characterization of ampholyte compositions without protein consumption, reducing analysis time and cost, and ensuring consistency across different ampholyte lots.

Implementation Method 1

liquid chromatography-mass spectrometry (LC-MS)

Methodology Applied
Scientific EffectChromatography: Chromatography

Implementation Method 2

mass spectrometry (LC-MS)

Methodology Applied
Scientific EffectIonization: Ionisation

Data Source

PatentUS20250251362A1Liquid chromatography- mass spectrometry (LC-ms) methods for analyzing ampholyte lot variation
Publication Date: 2025.08.07 REGENERON PHARMACEUTICALS INC
  • US20250251362A1 patent drawing
  • US20250251362A1 patent drawing
  • US20250251362A1 patent drawing

AI summary

The disclosure relates to methods of characterizing ampholyte compositions suitable for downstream applications such as capillary isoelectric focusing using liquid-chromatography-mass spectrometry.